Male patients with ER+ breast cancer tend to have grade 2 or 3 tumors, stage II or III disease, and progesterone receptor-positivity compared to female patients.

Niraparib maintenance has a tolerable safety profile in patients with ovarian cancer, with hematologic toxicities being “the primary concern,” according to researchers. They evaluated the safety of ...

Patients in the low TyG index group had higher survival rates than those in the high TyG group, and this result was maintained across patient subgroups.

Investigators used the Shiny method, which employs artificial intelligence, to indirectly compare the efficacy of novel systemic therapies for urothelial cancer using phase 3 trial data.

Researchers examined the risk associated with the development of secondary skin cancers vs other malignancies in patients with primary Merkel cell carcinoma.

HealthDay News — Childhood cancer survivors (CCS) have an increased risk for chronic kidney disease (CKD) and hypertension, according to a study published online May 19 in JAMA Network Open.

Most Americans surveyed said they do not support the Trump administration’s recent cuts to staff and spending at federal health agencies.

Despite its complexity, partial nephrectomy still provides the best survival rates among treatment options in patients aged 75 years or older with T1-T2 renal cell carcinoma (RCC). Investigators ...

Analysis of symptoms experienced by adolescents with cancer receiving chemotherapy were identified by prevalence, severity, and distress, and categorized into specific symptom clusters.

Regarding the pediatric population, mold-active antifungal prophylaxis is recommended for pediatric patients at high risk of IFD, including a subgroup of children with ALL.

HealthDay News — Short-term testosterone use among transmasculine and gender diverse (TMGD) individuals is not associated with an increased risk for gynecological cancers, according to a study ...

Researchers sought to determine whether a real-time personalized algorithm may help to effectively plan HDMTX infusion among pediatric patients with ALL.